Indication
Abdominal Aortic Aneurysm
8 clinical trials
9 products
2 drugs
Clinical trial
Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.Status: Recruiting, Estimated PCD: 2027-03-31
Product
Nectero EAST SystemProduct
Nectero EASTClinical trial
LIMItIng AAA With meTformin (LIMIT) TrialStatus: Recruiting, Estimated PCD: 2027-03-31
Drug
MetforminClinical trial
The Effect of Preoperative Dexamethasone on Postimplantation Syndrome After Endovascular Aneurysm Repair - Protocol for a Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-05-31
Product
DexamethasoneClinical trial
Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and RuptureStatus: Completed, Estimated PCD: 2022-02-01
Product
Contrast UltrasoundClinical trial
A Prospective Randomized, Double Blind, Placebo-controlled, Safety and Efficacy Study of Metformin as add-on Therapy in Non-diabetic Patients With Abdominal Aortic Aneurysm (MetAAA Study)Status: Active (not recruiting), Estimated PCD: 2024-05-01
Product
Metformin GlucophageProduct
PlaceboClinical trial
Metformin for AAA Growth Inhibition, a Randomized Controlled TrialStatus: , Estimated PCD: 2026-01-01
Clinical trial
ACTION-1: ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair, a Randomised Trial.Status: Active (not recruiting), Estimated PCD: 2024-05-01
Product
ACT guided heparinizationProduct
HeparinClinical trial
A Randomized, Placebo-Controlled Mechanistic Clinical Trial of PCSK9 Inhibition With Evolocumab in Patients Undergoing Open Abdominal Aortic Aneurysm RepairStatus: Not yet recruiting, Estimated PCD: 2028-11-01
Product
EvolocumabDrug
Varlilumab